CompletedNot Applicable

Prenatal Diagnosis of the Fetal Esophageal or Intestinal Atresia

France51 participantsStarted 2021-04-01

Plain-language summary

Aim- to investigate how prenatal diagnosis of fetal esophageal or intestinal atresia impacts obstetric and neonatal outcomes. Methods- This was a retrospective cohort study at a single center. The study population comprised 51 consecutive pregnancies, including 29 mothers (57%) and their fetuses affected by prenatally diagnosed fetal esophageal or intestinal atresia, and 22 mothers (43%) and their babies with postnatally diagnosed fetal esophageal or intestinal atresia.

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * all pregnancies affected by fetal esophageal, duodenal or intestinal atresia referred to our prenatal diagnosis unit * all newborns managed for such atresia in our unit of pediatric surgery Exclusion Criteria: * termination of pregnancy, * stillbirth, * the false positive cases

What they're measuring

gestational age of delivery

Timeframe: 1 year

mode of delivery

Timeframe: 1 year

Trial details

NCT IDNCT05362604

SponsorPoitiers University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-07

View on ClinicalTrials.gov More Antenatal Management of the Fetal Gastrointestinal Atresia trials